BCL2L1 and non-small cell lung carcinoma: As shown in Figure 4, TP53 (HR = 1.44 [1.27-1.64], logrank P = 1.4e − 08), CXCL8 (HR = 1.3 [1.15-1.47], logrank P = 4.6e − 05), BCL2L1 (HR = 1.38 [1.38-1.87], logrank P = 7.1e − 10), MMP9 (HR = 1.15 [1.01-1.3], logrank P = 0.032), and NOS2 (HR = 1.41 [1.21-1.63], logrank P = 5.2e − 06) high mRNA expressions were associated with significantly shorter OS in all NSCLC patients (P < 0.05); i.e., survival was lower in the high expression group than in the low expression group.